HRT Financial’s Inspire Medical Systems INSP Stock Holding History

HRT Financial’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,400	Closed	-$588K	–	4755
2026 Q1	$588K	Buy	+11,400	New	+$798K	﹤0.01%	2396

Other funds holding INSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

HRT Financial's INSP Position: Q1 2026 in Review

HRT Financial sold out of Inspire Medical Systems (INSP) in Q1 2026, closing a stake of 121,761 shares — an estimated $8.52M sold.

HRT Financial first reported a position in INSP in Q1 2019 and held it in 11 quarters. The position peaked at $27.2M in Q2 2023. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

HRT Financial reported no remaining Inspire Medical Systems position as of Q1 2026 after selling out during the quarter.
HRT Financial sold 121,761 Inspire Medical Systems shares in Q1 2026, an estimated $8.52M.
HRT Financial first reported a position in Inspire Medical Systems in Q1 2019 and held it in 11 quarters.
HRT Financial's Inspire Medical Systems position peaked at $27.2M in Q2 2023.
301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.